Nu-Med Plus, Inc. (NUMD)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenue | - | - | - | |
| Professional and consulting fees | 4,950 | 7,950 | 3,205 | |
| Rent expense | - | - | - | |
| General and administrative expense | 5,469 | 9,467 | 12,835 | |
| Total operating expenses | 10,419 | 17,417 | 16,040 | |
| Operating loss | -10,419 | -17,417 | -16,040 | |
| Interest expense | 1,246 | 1,260 | 1,247 | |
| Total other income (expense) | -1,246 | -1,260 | -1,247 | |
| Net loss before income tax | -11,665 | -18,677 | -17,287 | |
| Income tax expense | - | - | - | |
| Net loss | -11,665 | -18,677 | -17,287 | |
| Basic loss per share (in dollars per share) | - | - | - | |
| Diluted loss per share (in dollars per share) | - | - | - | |
| Weighted average common shares outstanding - basic (in shares) | 83,548,469 | 81,348,469 | 81,348,469 | |
| Weighted average common shares outstanding - diluted (in shares) | 83,548,469 | 81,348,469 | 81,348,469 | |